Skip to main content

Day: May 6, 2024

USI Insurance Services Acquires Hignojos Insurance Agency

New Partnership Expands USI’s Texas-Based Presence and Expertise VALHALLA, N.Y., May 06, 2024 (GLOBE NEWSWIRE) — USI Insurance Services (“USI”), a world leader in risk management, employee benefit and retirement plan consulting, today announced the acquisition of Odessa, Texas-based Hignojos Insurance Agency. Founded in 2009, Hignojos Insurance Agency is an independent brokerage firm specializing in commercial and personal risk insurance programs. Terms of the transaction were not disclosed. “We are thrilled to be joining forces with USI, an established industry leader in the insurance brokerage and consulting market,” stated Hignojos Insurance Agency Principal, Louis Hignojos Sr. “Our valued clients throughout western Texas and beyond will continue to benefit from the local, personalized services they have come to expect from...

Continue reading

Integra LifeSciences Reports First Quarter 2024 Financial Results

PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 HighlightsFirst quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding BostonFirst quarter GAAP earnings per diluted share of $(0.04), compared to $0.29 in the prior year; adjusted earnings per diluted share of $0.55, compared to $0.74 in the prior yearCompleted the acquisition of the Acclarent, Inc. on April 1Updating full-year 2024 revenue guidance to a range of $1.672 billion to $1.687 billion from a range of $1.603 billion to $1.618 billion...

Continue reading

Oculis to Present at Bank of America Global Healthcare Conference

ZUG, Switzerland, and BOSTON, USA, May 06, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”) a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the Bank of America Healthcare Conference taking place on May 14-16, 2024 in Las Vegas, NV. Riad Sherif, M.D., Chief Executive Officer of Oculis, will deliver a company presentation on Wednesday, May 15th at 11:20am PT at the Encore Hotel. A live webcast of the presentation will be available here. The Company will be available for one-on-one meetings during the conferences. Interested investors should contact their Bank of America representative to request meetings. A link to access company presentation, when available, will be...

Continue reading

ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $17.8 million in 1Q 2024; total operating expenses decreased 25% (adjusted total operating expenses decreased 16%)1 compared to 1Q 2023 Successfully completed LOTIS-7 dose escalation and initiated expansion in 2L+ DLBCL Initial MZL IIT Phase 2 data from 15 patients showed 13 patients with CR and 1 patient with PR; encouraging data compared to current treatments in area with high unmet medical need Research event featured next-generation ADC platform and the Company’s most advanced ADC targets including promising preclinical data in NaPi2b, Claudin-6, PSMA and ASCT2 Company to host conference call today at 8:30 a.m. EDT LAUSANNE, Switzerland, May 06, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today reported financial results for the first quarter ended March 31,...

Continue reading

AI and Big Data Take the Centre Stage in Central Asia at Beetech 2024 Hosted by Beeline Kazakhstan and QazCode

More than 1000 participants discussed the future of AI and big data at the Beetech 2024.More than 1000 participants discussed the future of AI and big data at the Beetech 2024 organised by Beeline Kazakhstan and Qazcode in Astana on 27 April 2024 1000 Kazakh and international delegates participate in the annual conference, discussing artificial intelligence, big data analytics and app development in the region Amsterdam and Astana, 6 May 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that its digital operator Beeline Kazakhstan together with IT subsidiary QazCode, one of the country’s largest software firms, have hosted the 2024 Beetech Conference in Astana to discuss the future of AI, big data and application development. ...

Continue reading

Pulsar Helium Announces Spring Road Restrictions End at Topaz Project

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) — Pulsar Helium Inc. (TSXV:PLSR & OTCQB:PSRHF) (“Pulsar” or the “Company”) is pleased to announce that the Minnesota Department of Transport has announced that Spring road restrictions in the north frost zone have ended (12:01 AM Monday, May 6). The Company will immediately recommence field operations at the Jetstream #1 appraisal well* at its flagship Topaz helium project. Activities will initially consist of road improvements and civil works, followed by down-hole logging, well completion, and flow testing with a pressure build up program. All necessary contracts are in place, with vendors and equipment secured to complete the upcoming works. Thomas Abraham-James, President and CEO said: “My colleagues and I are excited to obtain the outstanding data from Jetstream...

Continue reading

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma

Initial data from 15 patients with relapsed/refractory (r/r) marginal zone lymphoma (MZL) show 13 patients achieved a complete response and one patient achieved a partial response with ZYNLONTA® All patients achieving responses maintained them at the time of data cutoff ZYNLONTA was generally well-tolerated and safety was consistent with known profile Data were presented at Lymphoma Research Foundation’s 2024 Marginal Zone Lymphoma Scientific Workshop LAUSANNE, Switzerland, May 06, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced that initial data from an investigator-initiated Phase 2 clinical trial evaluating ZYNLONTA® (loncastuximab tesirine-lpyl) demonstrated a high response rate in patients with relapsed/refractory (r/r) marginal zone lymphoma (MZL). The 50-patient single-arm, open-label Phase 2 multicenter...

Continue reading

Godkendelse af afdelingsfusion og vedtægter i Investeringsforeningen SEBinvest

Med henvisning til fondsbørsmeddelelser af henholdsvis af 8. marts 2024 og 17. april 2024 offentliggøres det, at Finanstilsynet har godkendt afdelingsfusionen mellem AKL Nordamerika Aktier SRI I i Investeringsforeningen SEBinvest og AKL SEBinvest Nordamerika Aktier SRI II i Investeringsforeningen Wealth Invest, med sidstnævnte som den fortsættende afdeling. Fusionen gennemføres i henhold til den offentliggjorte fusionsplan og -redegørelse.  Finanstilsynet har desuden godkendt de vedtægtsændringer, som blev vedtaget på foreningens ordinære generalforsamling den 17. april 2024. De godkendte vedtægter er vedhæftet denne meddelelse.  For yderligere oplysninger kontakt venligst direktør Lise Bøgelund på telefon 3328 2828. Med venlig hilsen Investeringsforeningen SEBinvestAttachment2024 04 17 Vedtægter SEBinvest

Continue reading

Chinese variety show “Ride the Wind 2024” receives its first French singer Joyce Jonathan

Recently, the popular variety show “Ride the Wind 2024” produced by China’s Mango TV receives its first French singer Joyce Jonathan.French singer Joyce Jonathan debuts in the variety show Ride the Wind 2024. [Photo: Courtesy of Mango TV] CHANGSHA, China, May 06, 2024 (GLOBE NEWSWIRE) — This show is a music competition as well as international cultural exchange platform, featuring accomplished females from worldwide. In this show, 36 international female stars from France, the United States, Russia, China and other countries were invited. Their wonderful performances have been loved by many audiences, making “Ride the Wind 2024” outstanding among the likes. The show explores to integrate traditional Chinese cultural elements and a variety of other cultural styles, presented by the brilliant stage...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.